EUVIMEDEUVIMED entdecken
Crossref

Proliferative mechanism of benign prostatic hyperplasia by NLRP3 inflammasome through the complement pathway

Junya Hata iD, Kanako Matsuoka iD, Yuki Harigane, Kei Yaginuma, Hidenori Akaihata, Satoru Meguro iD, Ruriko Honda-Takinami, Akifumi Onagi, Yuichi Sato, Soichiro Ogawa iD, Motohide Uemura, Yoshiyuki Kojima

International Journal of Urology · 2024-12 · 31 (12) · 1429-1437

DOI: 10.1111/iju.15576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Urology, online erschienen am 11.09.2024. Verfasst von Junya Hata und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, Disease Models, Animal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The expressions of complement component C5a and NLRP3 inflammasome and the antiproliferative effect of resveratrol in benign prostatic hyperplasia (BPH) model rat were analyzed to clarify the BPH proliferative mechanism.

Methods

This study used the pathological stromal‐dominant BPH model rat by urogenital sinus implantation (UGS). Expression of C5a, NLRP3, Caspase‐1, IL‐1β, and IL‐18 using rat BPH tissues at 2, 3, and 8 weeks ( n = 6, respectively) after UGS implantation were analyzed by qRT‐PCR, western blotting analysis, and immunohistochemical (IHC) analysis. Serum IL‐1β levels in BPH model and sham rats were measured by enzyme‐linked immunosorbent assay. Furthermore, resveratrol, as the NLRP3 pathway inhibitor, was administered to BPH model rat to assess the antiproliferative effect on the BPH proliferative process. The proliferative effect on prostate was evaluated by Ki‐67 protein expression.

Results

The expression levels of C5a, NLRP3, Caspase‐1, IL‐1β, and IL‐18 in qRT‐PCR, western blotting, and IHC were significantly upregulated in BPH tissues compared to control prostate tissues and showed increases with time (all p < 0.05). Serum IL‐1β levels in BPH model rats had significantly increased compared to sham rats. On IHC, deposition of C5a, NLRP3, Caspase‐1, IL‐1β, and IL‐18 was abundant in stromal areas of BPH. The administration of resveratrol significantly decreased prostate weight and expressions of NLRP3, IL‐1β, IL‐18, and Ki‐67 (all p < 0.05).

Conclusions

NLRP3 inflammasome activation by complement C5a produces IL‐1β and IL‐18 through Caspase‐1 during the BPH proliferative process. NLRP3 inflammasome have the possibilities to be a therapeutic target for BPH proliferation by inhibiting the NLRP3 inflammasome pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic HyperplasiaNLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesDisease Models, AnimalRats, Sprague-DawleyCell ProliferationMaleAnimalsRatsProstateResveratrolInterleukin-18Interleukin-1betaCaspase 1

Stichwörter der Autor:innen

NLRP3 inflammasomebenign prostatic hyperplasiacomplement pathway

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesNlrp3 protein, ratResveratrolInterleukin-18Interleukin-1betaCaspase 1

Autor:innen und Institutionen

  • Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.

ORCID-Profile: Junya Hata, Kanako Matsuoka, Satoru Meguro, Soichiro Ogawa

Zitieren

APA

Hata, J., Matsuoka, K., Harigane, Y., Yaginuma, K., Akaihata, H., Meguro, S., Honda-Takinami, R., Onagi, A., Sato, Y., Ogawa, S., Uemura, M., & Kojima, Y. (2024). Proliferative mechanism of benign prostatic hyperplasia by NLRP3 inflammasome through the complement pathway. International Journal of Urology, 31(12), 1429-1437. https://doi.org/10.1111/iju.15576

Vancouver

Hata J, Matsuoka K, Harigane Y, Yaginuma K, Akaihata H, Meguro S, et al. Proliferative mechanism of benign prostatic hyperplasia by NLRP3 inflammasome through the complement pathway. International Journal of Urology. 2024;31(12):1429-1437. doi:10.1111/iju.15576

BibTeX
@article{Hata2024,
  author = {Hata, Junya and Matsuoka, Kanako and Harigane, Yuki and Yaginuma, Kei and Akaihata, Hidenori and Meguro, Satoru and Honda-Takinami, Ruriko and Onagi, Akifumi and Sato, Yuichi and Ogawa, Soichiro and Uemura, Motohide and Kojima, Yoshiyuki},
  title = {Proliferative mechanism of benign prostatic hyperplasia by NLRP3 inflammasome through the complement pathway},
  journal = {International Journal of Urology},
  year = {2024},
  volume = {31},
  number = {12},
  pages = {1429--1437},
  doi = {10.1111/iju.15576}
}
Kostenlos starten →